All In MedTech

Device Trial Radar · NCT05237310

Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy

Dual Tandem Study Comparing the Adenoma Detection and Miss-rate of Standard Colonoscopy to That of Artificial Intelligence (CAD-EYE) and to That of Artificial Intelligence (CAD-EYE) and G-EYE® Aided Colonoscopy

Last checked: Nov 19, 2026Latest source record: Mar 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 372 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

372

Planned (sponsor's estimate)

Start

Feb 2, 2022

Primary completion

Aug 2022

Study completion Sep 2022

Sponsor

Lead sponsor
Smart Medical Systems Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
Fujifilm
First posted
Feb 14, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the additional diagnostic yield over Standard Colonoscopy (i.e., the adenoma miss-rate reduction) obtained by performing CADEYE and G-EYE® aided colonoscopy, vs. the additional diagnostic yield over Standard Colonoscopy (i.e., the adenoma miss-rate reduction) obtained by performing CAD-EYE aided colonoscopy.

Conditions

  • Colorectal Cancer
  • Adenoma

Interventions

  • Standard ColonoscopyDevice

    Standard Colonoscopy using a standard Fujifilm colonoscope

  • G-EYE ColonoscopyDevice

    G-EYE Colonoscopy performed using SMART Medical G-EYE Colonoscope

  • CAD-EYEDevice

    Colonoscopy performed using with the aid of Fujifilm CAD-EYE artificial intelligence

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Additional Adenoma DetectionTime frame: Upon histology results (up to 30 days)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH

    Wiesbaden, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.